| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich existing question and record are being presented in the sheet?Required |
The selected question is 'ICDAS remineralization of white spots'; the question and existing verdict record are distinguished. The parent concerns lesion remineralization after orthodontic treatment, while the sibling concerns a different outcome, prevention of incident caries. |
Some information from the stored summary was linked for production. The original candidate-boundary review wait is historical information; no model content/boundary review was performed in this work. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Relationships among the original question, record and parent/sibling outcomes |
If additional material is provided, a linked outcome text retaining the original existing question and its connection |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionHow are the subclaim C/note, parent C50 and missing scores/axes distinguished?Required |
The original subclaim grade C and note 'Score improvement was confirmed' are retained. Subclaim scores/status/axes are absent; the parent C50, Good status and axes are parent history. |
Some information from the stored summary was linked for production. There are no direct values for the selected subclaim score, status or axes. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
A separate record of original subclaim/parent verdicts, notes, scores/axes and missing values |
If an actual verdict correction is provided, separate the complete original text, event/version and change decision |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWhat is shared among one report, lesions/patients and sibling questions?Required |
Ciribè et al. 2024, PMID38927409, occupies 1 slot in each evidence/citation list. The same trial's patients, lesions/teeth, baseline/six months, safety and unmeasured caries-prevention context are linked. |
Some information from the stored summary was linked for production. Follow-up/other report versions, overlapping populations, lesion/tooth relationships and current unique trial/participant totals are unresolved. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Relationship table for bibliography/trial families, patients/teeth/lesions and times/outcomes |
If additional reports are provided, distinguish relationships among the same populations/reports/outcomes and separate material |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat are the actual summary-reading and external original-material statuses?Required |
The complete specified stored summary was read for production and the original was preserved. The original PubMed URL is only linked; external abstracts, full texts, registrations and plans are unread. |
Some information from the stored summary was linked for production. External public availability/acquisition, current content, access success and link operation were not verified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Stored summaries and external original-material existence/acquisition, reading level and original locations |
When further acquisition is allowed, record actual reading/attempts and dates separately |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionWhat is the scope of white spots after orthodontic treatment and the actual population?Required |
The original question concerns white spots after orthodontic treatment, and the existing English research description says 'randomized adolescents'. Each Korean/English population wording is preserved as recorded. |
Some information from the stored summary was linked for production. Age range, sex, baseline lesion/caries risk, orthodontic/retainer status, eligibility/exclusions and recruitment are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original population eligibility/exclusions, baseline risk, age and orthodontic-status table |
Same-trial material specifying the selected population and direct outcomes, or appropriate separate material |
| 6 |
Unverified |
Full text not readStored summary read |
N06 · Evidence conditionWhat are the baseline lesion/tooth distribution and assessment conditions?Required |
The original material presents patient counts and arm-specific baseline/six-month ICDAS values, but no separate lesion location, tooth/patient distribution or assessment environment. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Teeth/surfaces, lesion counts, lesion criteria, photography/drying, orthodontic completion timing, assessment environment and baseline balance are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original lesion/tooth distribution, selection criteria and assessment-environment/baseline table |
Original material linking patient/lesion baseline status to measurement conditions |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWhat are the original F-ACP ingredients and the other CPP-ACP product families?Required |
The existing product information states that F-ACP is an amorphous calcium phosphate complex containing fluoride and carbonate. Marketing of fluoride/CPP-ACP product families in the existing advertising interpretation is a different-product-family context. |
Some information from the stored summary was linked for production. The finished trial product/manufacturer, ingredient concentrations, other additives, batches, provision/quality and equivalence between products are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Trial-product identity, composition/concentration and original product/provision information |
Material specifying applicability differences between the actual trial product and other compositions/products |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionWhat is the scope of six-month research exposure inside an Essix retainer?Required |
The original research condition involved applying mousse inside an Essix retainer for six months. The combined product, retainer and duration exposure is recorded as originally stated. |
Some information from the stored summary was linked for production. Application amount, frequency, retainer wear/cleaning, actual adherence, discontinuations/changes, contact time and route details are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original product/retainer exposure, nominal/actual use and adherence/change material |
Original implementation material linking actual exposure and outcomes in the same study |
| 9 |
Unverified |
Full text not readStored summary read |
N09 · Evidence conditionWere the control arm's fluoride and basic treatment conditions directly reported?Required |
The existing verdict rationale records control-arm ICDAS values, but the specified summary contains no control product/fluoride ingredients, concentrations or exposure. F-ACP's fluoride ingredients and product-family marketing are not control treatment. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Direct definitions of control-arm fluoride/toothpaste, retainers, placebo/no treatment, hygiene/diet and common/arm-specific care are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original control treatment, product/concentration, common/arm-specific care and actual implementation |
Protocol/report specifying the actual control and concurrent conditions in the same trial |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionWhat are the denominators for 106 randomized, 91 completers and 52/39 participants?Required |
The original n is 106 randomized and 91 completers analyzed; the existing Korean research description records 52 mousse and 39 control participants. Each number is an original patient-denominator record. |
Some information from the stored summary was linked for production. Randomized n by arm, selection/exposure/completion/assessment flow, tooth/lesion counts and original counts by exclusion reason are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Allocation → exposure → completion/assessment → analysis, and patient/lesion denominator tables |
Same-trial material linking arm-specific flow to original denominators for each unit |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionWhat is the scope of the original 14.2% dropout and completer selection?Required |
The original records 91/106, 14.2% dropout and completer analysis. Dropout rates, analysis inclusion and original observation/exposure are distinguished. |
Some information from the stored summary was linked for production. Arm-specific dropout/nonadherence, timing/reasons, dropout baseline/outcomes, missing-data handling and sensitivity are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original dropout/exclusion, follow-up, baseline/missing-data handling and analysis flow |
Same-trial material specifying completer/noncompleter data and original analysis assumptions |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionWhat are the original randomization, concealment and design details?Required |
The evidence-list design is a randomized controlled trial. Actual allocation, concealment and baseline-balance details require material separately from the original subclaim/parent verdicts. |
Some information from the stored summary was linked for production. The summary lacks parallel/cluster/crossover design, random-sequence/allocation concealment, baseline balance and implementation-role details. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original allocation/design, concealment, baseline tables and implementation material |
Material specifying the actual comparative design in the protocol/report |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionWhat are the ICDAS assessment, masking and measurement reliability?Required |
The original endpoint is the six-month ICDAS white-spot score. The original indicates greater lesion severity with higher scores, but assessors/masking and examination conditions are separate matters. |
Some information from the stored summary was linked for production. ICDAS version, assessors/calibration, masking, photographs/examinations, inter-assessment agreement, missing assessments and arm differences are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original ICDAS criteria, assessors/masking, measurement conditions and reliability material |
Original methods/appendices linking actual readings, measurement limitations and results |
| 14 |
Unverified |
Full text not readStored summary read |
N14 · Evidence conditionAre patient, tooth and lesion units distinguished from repeated measurements?Required |
The original explanation identifies n as people and ICDAS as lesion scores. Multiple teeth/lesions and baseline/six-month values from the same person are not counted as independent participants. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. ICDAS aggregation units, lesions per patient, selected teeth/surfaces, cluster/repeated-measure handling and denominators are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Patient–tooth–lesion relationships, aggregation/models and unit-specific denominator/measurement tables |
Material specifying original measurement units and within-patient correlation/repeated measurements |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionWhat are six-month ICDAS, nominal exposure and assessment timing?Required |
The original records six-month ICDAS and six-month retainer/mousse exposure. Individual actual use duration, assessment windows and intermediate measurements are separate matters. |
Some information from the stored summary was linked for production. Orthodontic completion/baseline, final assessment timing, allowed windows, intermediate times, data cutoff and actual exposure/safety follow-up are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original schedules, baseline/six months, actual exposure/assessment and missing-data material |
Same-trial material linking assessment windows/exposure and time-specific outcomes |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionWhat is the original direction of baseline and six-month final values?Required |
The existing Korean verdict rationale records mousse 1.80→1.00 points and control 1.92→1.53 points. The original explanation that higher is worse and reduction indicates improvement is retained. |
Some information from the stored summary was linked for production. Details of each value's mean/median, dispersion/CI, aggregation/measurement unit, adjustment and original timing are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original baseline/final tables, aggregation/dispersion, units/denominators and models |
The same report providing original final/baseline values, dispersion and outcome units |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionWhat do changes of 0.80 versus 0.39 points represent?Required |
The original ICDAS reductions are 0.80 versus 0.39 points. Positively expressed reductions are recorded alongside the lower-is-better direction of final ICDAS values. |
Some information from the stored summary was linked for production. Details of sign/aggregation, change dispersion, paired measurements/adjustment and within-arm versus between-arm tests are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original change definitions, sign/units, dispersion, analysis methods and tables |
Material reporting changes/final values and distinguishing within-arm/between-arm results |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat is the level of the original 0.41-point difference in change?Required |
The existing Korean verdict rationale records a 0.41-point difference in change. This existing original value is preserved; its model, CI and importance remain separate matters. |
Some information from the stored summary was linked for production. Adjustment, dispersion/CI, aggregation/clustering/repeated measurements and clinical-importance criteria are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original between-arm change differences, models/units and CI/criterion tables |
Material reporting definitions/intervals and importance of original between-arm outcomes |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionWhat are between-arm P=0.003 and the effect interval?Required |
The evidence list records between-arm P=0.003 and the existing English text records P=.003. These are retained alongside the original direction of ICDAS changes; P is distinguished from effect size/intervals. |
Some information from the stored summary was linked for production. Original tests/models, CIs, dispersion, multiplicity, measurement/analysis units and importance are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original statistical methods, test targets, effects/CIs and unit material |
Original result tables linking actual models/intervals and testing objectives |
| 20 |
Unverified |
Full text not readStored summary read |
N20 · Evidence conditionWhat are score aggregation, models and within-arm/between-arm analyses?Required |
The original records ICDAS baseline/final values, changes and between-arm P. The summary does not explain models for score means, categories/stages or patient/lesion aggregation. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Scale treatment, aggregation, baseline adjustment, clustering/repeated measurements, analysis assumptions, sensitivity and change dispersion are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original score aggregation/statistical methods, SAP, models/units and tables |
Material specifying original ICDAS analysis with units, models and assumptions |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionHow do completer effects differ from effects in the full randomized population?Required |
The original main result is a 91/106 completer analysis; the parent verdict historically described this defect as avoidable through ITT/missing-data handling. Actual ITT results were not provided. |
Some information from the stored summary was linked for production. Allocation/adherence effects, completion selection, arm-specific exclusions and original ITT/sensitivity outcomes are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original analysis populations, completion/exclusions, missing-data assumptions and alternative analyses |
Material reporting randomized/completer populations and the actual scope of missing data |
| 22 |
Unverified |
Full text not readStored summary read |
N22 · Evidence conditionWhat are the reported intervals and criteria for an important ICDAS difference?Required |
Original changes/differences and P are retained. Although ICDAS is lower-is-better, the summary lacks justified important-difference/patient-utility criteria and CIs. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Minimum important differences, stage/lesion-recovery criteria, intervals/dispersion and power/original plans are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original importance/clinical-linkage criteria, effect intervals and planning assumptions |
If justified original criteria are provided, link them with score differences/intervals |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionWhat do registration 'Not confirmed', prespecification and plans mean?Required |
The existing registration identifier record is the string 'Not confirmed'. The current registration ID remains null; this original record and unverified scope are retained. |
Some information from the stored summary was linked for production. Registration/protocol/SAP, original primary/secondary outcomes, analyses/times and change history are externally unread. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original registration/plans, endpoints/times, analysis versions and change material |
If actual plans are provided, distinguish original unverified status from new additional events/comparison scope |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Evidence conditionWhat is the scope of multiplicity and disclosure of all outcomes/times?Required |
The original material contains six-month ICDAS, adverse-effect reporting and unmeasured caries context. It does not provide a complete primary/secondary endpoint, time or analysis list. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Full outcome lists, multiplicity adjustment, exploratory/confirmatory status, prespecified analyses/changes and unpublished outcomes are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Protocol/SAP, all outcomes/times and reporting/change tables |
Material linking original plans and reports by outcome |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionWhat are the original verdict and unmeasured scope for sibling caries prevention?Required |
The caries-prevention sheet concerns 'Prevention of incident caries', with grade '?' and the note 'Not measured'. The parent verdict states that reduced new caries/filling treatment was not measured. |
Some information from the stored summary was linked for production. Original clinical-event definitions/collection, long-term outcomes, registration plans and current related material were not verified in this work. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
The same trial's outcome list and direct clinical-event material for the prevention question |
If direct event material is provided, distinguish connections for remineralization from separate questions/scopes |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionDoes ICDAS remineralization also answer questions about new caries, fillings or tooth loss?Required |
The selected outcome is a lesion-score surrogate. The existing core explanation/counterview states that improved scores cannot be transferred to reduced caries incidence or filling treatment. |
Some information from the stored summary was linked for production. Direct clinical-event effects, units/denominators, duration, surrogate prediction/mediation and long-term material are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Direct definitions, denominators and durations for new caries/treatment and tooth outcomes, with related validation |
If appropriate direct event material is provided, link scores and clinical outcomes separately |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Evidence conditionAre visual improvement and benefits in patient appearance/daily life the same?Supplementary; required for extension to daily-life benefits |
The existing counterview states that visual/score-based remineralization may be useful to patients. It does not provide direct patient satisfaction, appearance/pain or quality-of-life values. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Patient-reported appearance/satisfaction, daily life/quality of life, symptoms, persistence, importance and denominators are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Patient-centered outcomes/scales, definitions, denominators/times and original results |
If material directly reporting patient-centered outcomes is provided, distinguish it from lesion scores |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionWhat are the concurrent or alternative effects of hygiene, fluoride, diet and retainers?Required |
The original comparison concerns lesion-score changes with F-ACP mousse/Essix. The summary lacks actual balance in basic oral care, other products/diet and natural recovery. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Arm-specific concurrent fluoride/toothpaste, diet/hygiene, retainers, natural course, intervention/assessment differences and handling methods are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Control/concurrent treatment, actual behavior/adherence and original baseline/analysis material |
Material linking common/different exposures and the original effect of interest in the same randomized comparison |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionWhat are actual adherence, discontinuations and duration/dose comparisons?Required |
Six-month mousse exposure inside Essix is a nominal research condition. Actual individual adherence, dose reduction/discontinuation and direct comparisons of other durations/products are not separately provided. |
Some information from the stored summary was linked for production. Adherence measurement/distribution, discontinuations/changes, actual contact/amount and direct frequency/duration/formulation comparisons are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original adherence/changes, exposure and direct-comparison/SAP material |
Material distinguishing direct exposure-specific outcomes in the same or appropriate additional research |
| 30 |
Unverified |
Full text not readStored summary read |
N30 · Evidence conditionWhat direct material addresses other populations, subgroups and long-term maintenance?Supplementary; required for extension |
The original is a six-month lesion-surrogate trial in post-orthodontic white spots. Other ages/lesion risks, during-orthodontic/non-orthodontic settings and persistence after stopping are separate questions. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Prespecified subgroups/interactions, direct population/product comparisons, longer follow-up and persistence after stopping are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Extended populations/exposures, prespecified subgroups and duration-specific direct outcomes |
If additional material is provided, specify differences from original populations, exposures and times in the connection |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionDo single-trial/R1/I1 history and current independent replication differ?Required |
The parent records a small single trial and R1/I1 in the original verdict. The 1 evidence/citation slot, patients/teeth/lesions and two siblings are not current independent replications. |
Some information from the stored summary was linked for production. Current additional/follow-up reports, direct replication in other populations/products and material-family/independence relationships were not newly searched. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Report/trial/population, product/source and outcome relationships, with direct independent material |
If material is provided, list same/separate/unclear populations and distinguish verification levels |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Evidence conditionWhat history is represented by the original small-study/completer and duration defect descriptions?Required |
The parent verdict records two listed defects: fewer than 200 participants and completer analysis. It explains that six months was not counted because it was not shorter than 12 weeks. This is parent-score/verdict history. |
Some information from the stored summary was linked for production. These case-specific conditions did not automatically adopt the original 200 participants/12 weeks as minimum criteria or reassess them as new defect scores. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Complete parent-verdict history and actual design/analysis material |
If corrections/method changes are provided, preserve original history separately from new events |
| 33 |
Partly verified |
Full text not readStored summary read |
N33 · Evidence conditionWhat is the scope of no patient/guardian-reported adverse effects over six months?Required |
The existing safety description states that patients or guardians reported no adverse effects over six months. The original parent Good safety status is preserved separately from this reporting scope. |
Some information from the stored summary was linked for production. Event definitions, systematic/spontaneous collection, grades/discontinuations, original safety denominators and actual records/verification are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original adverse-effect reporting/collection, population/duration and definition/discontinuation material |
Original material specifying reporting methods and the actual safety scope for the same exposure |
| 34 |
Unverified |
Full text not readStored summary read |
N34 · Evidence conditionWhat are the adverse-effect denominators, dropout and reporting selection?Required |
The original 91/106 completers and 52/39 participants form the efficacy-analysis population. The summary does not distinguish whether patient/guardian adverse-effect reporting covered all randomized participants, completers or those actually exposed. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Safety populations, reporting/exposure/follow-up, events among dropouts, missing reports/recall and arm-specific detection differences are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original safety-population/exposure, collection/missing reports and dropout/follow-up tables |
Safety material specifying denominators and reporting/follow-up selection |
| 35 |
Unverified |
Full text not readStored summary read |
N35 · Evidence conditionWhat are harm occurrence, discontinuation and exposure/follow-up times?Required |
The original safety-reporting window is six months. Actual mousse/retainer exposure, onset/recovery, discontinuation/reuse and subsequent observation require separate material. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Event chronology, actual contact duration, discontinuation/re-exposure, collection windows/original cutoff and loss to follow-up are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original exposure/events, collection/discontinuation/recovery and timing material |
Original material specifying actual time and safety follow-up for the same exposure |
| 36 |
Unverified |
Full text not readStored summary read |
N36 · Evidence conditionWhat are the harm or alternative causes involving ingredients, retainers and baseline conditions?Supplementary; required for extension of harm questions |
The original exposure concerns fluoride/carbonate-containing F-ACP and Essix. The summary lacks contributions from other ingredients/retainers, baseline oral conditions/exposures and possible events. |
The required direct details were not verified within the current stored-summary and unread-external-material scope. Additives, baseline/concurrent conditions, other products, actual exposure, attribution/alternatives, vulnerable populations/long-term and rare harms are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original ingredients/products, baseline/concurrent conditions, event attribution and long-term/population-specific safety |
If appropriate direct safety material is provided, distinguish differences from the original exposure/reporting scope |
| 37 |
Partly verified |
Full text not readStored summary read |
N37 · Evidence conditionWhat is the original funding statement about no external funding?Required |
The original evidence-list funding phrase 'This research received no external funding' and the Korean/English funding-check descriptions are retained. Original checked scope is distinguished from current reading. |
Some information from the stored summary was linked for production. Original contracts, institutional/internal funding, sponsor/author roles, complete COI and data access are externally unread. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original funding/resources, design/collection/analysis/publication roles and COI material |
If actual original declarations are provided, record checked levels/locations separately from unverified scope |
| 38 |
Partly verified |
Full text not readStored summary read |
N38 · Evidence conditionDoes unverified product-provision wording differ from actual absence of provision?Required |
The original records that trial-product provision wording was not identified in the publicly checked COI/acknowledgments. Parent I1 represents that historical checked scope. |
Some information from the stored summary was linked for production. Complete product supply/in-kind support, author employment/patents, COI/acknowledgments, contracts and current changes are unverified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original product-provision/contracts, COI/acknowledgments and role declarations |
If original documents are provided, distinguish unverified/unreported status from the actual scope of provision/absence |
| 39 |
Partly verified |
Full text not readStored summary read |
N39 · Evidence conditionWhat are the Korean/English texts, parent axes, false/null values and verdict history?Required |
The parent C50/Good status, axes B/S/R1/I1/E+/B2, unrecorded precision, false coprimary-split/large hard-endpoint RCT/no-human-study flags and empty override reasons are preserved as originally recorded. Korean/English texts, synthesis, grade decisions and cross-checking are historical context. |
Some information from the stored summary was linked for production. Original values/axes and historical checks were not inherited as current subclaim scores, condition fulfillment or completed review. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Separate preservation of subclaim/parent, original languages/axes/empty values and verdict history |
If actual corrections are provided, distinguish complete original text, events/versions and decisions by scope |
| 40 |
Partly verified |
Full text not readStored summary read |
N40 · Evidence conditionDo the reference date, corrections/empty values differ from production dates/scope?Required |
The original reference date 2026-08-26, empty corrections/deliberation and the 2024 bibliography/unverified registration record are preserved. Current time belongs to a production event. |
Some information from the stored summary was linked for production. Evidence reference-date/classification records are absent, and no registration/correction/retraction, new search/material or link comparison was performed. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Original publication/search/registration/correction versions and current production events |
If material/corrections are actually provided, distinguish original scope, complete before/after text and new events |
| 41 |
Partly verified |
Full text not readStored summary read |
N41 · Evidence conditionWhat are the boundaries between score benefits/reported harms and current applicability/product selection?Required |
This sheet records ICDAS remineralization for the specified existing question and gaps in denominators/exposure, surrogates, safety and sponsorship in the same report. Individual dental products/use, treatment selection and current suitability are separate matters. |
Some information from the stored summary was linked for production. Current products/guidelines, individual oral status, other compositions/controls and direct material on current benefit/harm applicability were not verified. Review of the existing content is incomplete; this does not certify fulfillment of clinical conditions, zero effect or absence of material. |
Direct material for extended populations/exposures, clinical events/patient outcomes and harms, with applicability differences |
If material is provided and the scope allows, update research gaps while distinguishing the original sheet from other applicability questions |